Kyle Carver has sold EVMN and made no open-market buys since Jun 2026
Chief Financial Officer at Evommune, Inc.
SEC CIK 0001757072 · Filings on SEC.gov ↗
$0Bought
$415KSold
NoneLast buy
Every filing
1 filing since Jun 2026, newest first
Filings come from SEC EDGAR. Not investment advice.